These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38931337)

  • 1. Microbicides for Topical HIV Immunoprophylaxis: Current Status and Future Prospects.
    Zhernov YV; Petrova VO; Simanduyev MY; Shcherbakov DV; Polibin RV; Mitrokhin OV; Basov AA; Zabroda NN; Vysochanskaya SO; Al-Khaleefa E; Pashayeva KR; Feyziyeva NY
    Pharmaceuticals (Basel); 2024 May; 17(6):. PubMed ID: 38931337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS.
    Gupta SK; Nutan
    HIV AIDS (Auckl); 2013 Oct; 5():295-307. PubMed ID: 24174883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical microbicides for prevention of sexually transmitted infections.
    Obiero J; Mwethera PG; Wiysonge CS
    Cochrane Database Syst Rev; 2012 Jun; (6):CD007961. PubMed ID: 22696373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides.
    Madan RP; Keller MJ; Herold BC
    Curr Opin Infect Dis; 2006 Feb; 19(1):49-54. PubMed ID: 16374218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides.
    Rodríguez-Izquierdo I; Sepúlveda-Crespo D; Lasso JM; Resino S; Muñoz-Fernández MÁ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1774. PubMed ID: 35018739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will integrase inhibitors be used as microbicides?
    Crucitti GC; Botta M; Di Santo R
    Curr HIV Res; 2012 Jan; 10(1):36-41. PubMed ID: 22264044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.
    Notario-Pérez F; Ruiz-Caro R; Veiga-Ochoa MD
    Drug Des Devel Ther; 2017; 11():1767-1787. PubMed ID: 28670111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides.
    Vacas-Córdoba E; Galán M; de la Mata FJ; Gómez R; Pion M; Muñoz-Fernández MÁ
    Int J Nanomedicine; 2014; 9():3591-600. PubMed ID: 25114528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections.
    Sepúlveda-Crespo D; Ceña-Díez R; Jiménez JL; Ángeles Muñoz-Fernández M
    Med Res Rev; 2017 Jan; 37(1):149-179. PubMed ID: 27518199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraceptives of the future in the light of HIV infection.
    Short RV
    Aust N Z J Obstet Gynaecol; 1994 Jun; 34(3):330-2. PubMed ID: 7848210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal microbicides to prevent human immunodeficiency virus infection in women: perspectives on the female genital tract, sexual maturity and mucosal inflammation.
    Roberts L; Liebenberg L; Barnabas S; Passmore JA
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):441-9. PubMed ID: 22429786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
    Dhawan D; Mayer KH
    J Infect Dis; 2006 Jan; 193(1):36-44. PubMed ID: 16323129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbicides and HIV: A Review and an update.
    Naswa S; Marfatia YS; Prasad TL
    Indian J Sex Transm Dis AIDS; 2012 Jul; 33(2):81-90. PubMed ID: 23188931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal microbicides and the prevention of HIV transmission.
    Cutler B; Justman J
    Lancet Infect Dis; 2008 Nov; 8(11):685-97. PubMed ID: 18992405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbicides for prevention of transmission of sexually transmitted diseases.
    Howett MK; Kuhl JP
    Curr Pharm Des; 2005; 11(29):3731-46. PubMed ID: 16305508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Success With Microbicides and Pre-Exposure Prophylaxis for Human Immunodeficiency Virus (HIV): Is Female-Controlled Prevention the Answer to the HIV Epidemic?
    Opoku-Anane J; Diouf K; Nour NM
    Rev Obstet Gynecol; 2012; 5(1):50-5. PubMed ID: 22582127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical microbicides for preventing sexually transmitted infections.
    Obiero J; Ogongo P; Mwethera PG; Wiysonge CS
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007961. PubMed ID: 33719075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbicides: a new hope for HIV prevention.
    ; Gupta SK
    Indian J Med Res; 2011 Dec; 134(6):939-49. PubMed ID: 22310826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV microbicides: where are we now?
    Quiñones-Mateu ME; Vanham G
    Curr HIV Res; 2012 Jan; 10(1):1-2. PubMed ID: 22264039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.